self injection semaglutide .25mg Semaglutide Weight Loss FAQs: Everything

Description

Results from the Novo Nordisk-funded FLOW trial, published in May 2024, also suggested that semaglutide reduced the risk of clinically important kidney outcomes and death from cardiovascular causes in patients with T2DM and chronic kidney disease (CKD), with the risk of a primary-outcome event 24% lower in the semaglutide group than placebo

Researchers havent fully established exactly why Wegovy causes fatigue, as this specific side effect hasnt been extensively studied yet

This is the worst the GLP drugs will ever be The smartest person I know in medicine, Dave Park, has told me the only reason surgeons ever have something to do is because medicine hasnt figured out how to solve the problem yet. And in that spirit, todays newsletter is about celebrating the advances in the field of the GLP drugs, which are solving a problem I didnt think medicine would ever solve: curing obesity and metabolic syndrome in our modern food and movement environment

Studies incorporating formal measures of body compositiondistinguishing between fat mass and muscle masscould provide additional insights, as weight loss may result from reductions in both, and the degree of each may differ between individuals and between drivers of weight loss